tinnitus
Conditions
Interventions
Stomin A (Nicotinamide/Papaverine Hydrochloride)
carbogen (5% CO2 and 95% oxygen)
Sponsors
Department of Otolaryngology, Nagsaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Men and women over 20 years old 2. having inner ear symptoms such as hearing loss,tinnitus, aural fullness, and hyperacusis. 3. having unilateral or bilateral sensorineural (or mixed) hearing disturbance in a pure tone audiometry. 4. having tinnitus over 3 months worry it. 5. therapy for tinnitus has not been performed over one month before the admission.
Exclusion criteria
Exclusion criteria: 1. tinnitus with conductive hearing loss and/or with no hearing loss. 2. acute or subacute period within 3 months when patients have had tinnitus and hearing disturbance. 3. patients who are not worry about tinnitus. 4. patients having atelectasis of the lung and/or chronic obstructive pulmonary disease or patients suspected with these. 5. Patients with drug allegry. 6. Pregnant or post-pregnant patients giving milk.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The intention whose patients with chronic tinnitus would like to take carbogen (95% oxygen and 5% CO2) inhalation for tinnitus continuously. | — |
Secondary
| Measure | Time frame |
|---|---|
| THI (tinnitus handicap inventory) is perfomed 2 weeks later, one month later, 2 months later, just before the restart of the therapy, 2 weeks later of the tharapy restarted, one month later of the therapy restarted. | — |
Countries
Japan
Contacts
Public ContactHidetaka Kumagami
Nagasaki University Otolaryngology
Outcome results
None listed